Baidu
map

Discontinuation of second- versus first-line disease-modifying treatment in middle-aged patients with multiple sclerosis

Chappuis, M; Rousseau, C; Bajeux, E; Wiertlewski, S; Laplaud, D; Le Page, E; Michel, L; Edan, G; Kerbrat, A

Chappuis, M (通讯作者),Univ Hosp, Dept Neurol, Rennes, France.

JOURNAL OF NEUROLOGY, 2023; 270 (1): 413

Abstract

Background and purpose There has been scant research on the consequences of discontinuing second-line disease-modifying treatment (DMT) in middle-aged......

Full Text Link


Baidu
map
Baidu
map
Baidu
map